Study advises against high-dose intravenous vitamin C for burn patients due to mortality risk

An international clinical trial, the VICTORY trial, has found that high-dose intravenous vitamin C does not improve outcomes for patients with large burns and may even increase their mortality risk. Published in JAMA, these findings challenge previous assumptions about the treatment. The study suggests that routine administration of high-dose vitamin C in burn patients should be reevaluated.